Received Mar 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | 7+ | 3044069 | IM / RA |
ON 3/23/2025 @1830 RESIDENT NOTED WITH SHALLOW RESPIRATIONS W/ USE OF ACCESSORY MUSCLES. VS: BP 134/93, P 60 REGULAR, RR 12, T 97.3 SPO2 100% ON 2L VIA NON-REBREATHER MASK, PALE SKIN, RESIDENT NOTED WITH +1 BILATERAL EDEMA TO LEGS. MD NOTIFIED WITH ORDER TO TRANSFER TO HOSPITAL FOR FURTHER EVALUATION. DX OF RESPIRATORY FAILURE @ HOSPITAL.
2/13/2025 DX OF RESPIRATORY SYNCYTIAL VIRUS
DYSPHAGIA, OROPHARYNGEAL PHASE; DIFFICULTY IN WALKING, NOT ELSEWHERE CLASSIFIED; TYPE 2 DIABETES MELLITUS WITH DIABETIC CHRONIC KIDNEY DISEASE; HYPERTENSIVE HEART AND CHRONIC KIDNEY DISEASE WITHOUT HEART FAILURE, WITH STAGE 1 THROUGH STAGE 4 CHRONIC KIDNEY DISEASE, OR UNSPECIFIED CHRONIC KIDNEY DISEASE; METABOLIC ENCEPHALOPATHY; ACUTE RESPIRATORY FAILURE WITH HYPOXIA; PNEUMONIA DUE TO METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRESENCE OF CARDIAC PACEMAKER; HYPERPARATHYROIDISM; UNSPECIFIED ATRIAL FIBRILLATION.
Eliquis Oral Tablet (Apixaban); Rena-Vite Oral Tablet (B-Complex w/ C & Folic Acid); Ferrous Sulfate Oral Tablet 325 (65 Fe) MG (Ferrous Sulfate); Ipratropium-Albuterol Solution 0.5-2.5 (3) MG/3ML; Fleet Saline Enema Rectal Enema 7-19 GM/1
PENICILLIN, SINVASTATIN, FOSAMAX, NSAIDS
N/A